Do beta-Catenin and ras oncogenes detect most human colorectal cancer?
The results suggest that although oncogenic activation of beta-catenin and K-ras is independent in the process of clinical cancer development, combined analysis of the two major oncogenes can detect most colorectal cancers and identify a subset of patients with poorer outcomes. Consequently, activation of either or both of these oncogenes may serve as a genetic marker for molecular diagnosis.
This method is accurate, reliable and provides a scientific basis for controlling the quality of the stems of Actinidia deliciosa.